Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats
- PMID: 15010859
Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats
Abstract
Recent studies have suggested that probiotics or short chain fatty acids (SCFAs) exert a therapeutic effect on inflammatory bowel disease (IBD) patients. In a previous study, we demonstrated that Clostridium butyricum produces high levels of SCFAs in culture. In addition, a yogurt-based additive effectively masked, completely eliminating the unpleasant odor derived from the SCFAs. We recently reported that the oral administration of both high and low dose diets (50% w/w for 17 days and 5% w/w for 16 months, respectively) of the Clostridium butyricum derivative did not cause pathological abnormalities in rats. In the present study, we evaluated the effects of this product against dextran sulfate sodium (DSS)-induced experimental colitis in rats. Five-week-old male Wistar Hannover GALAS rats were given a mixture of a standard diet containing 3% (w/w) of DSS for 8 days. In the derivative-fed group, Clostridium butyricum derivative (20% w/w) with 0.1% (w/w) additive was also added to their diet. The control-fed group was given tap water (20% w/w) with 0.1% (w/w) additive. After 8 days, a laparotomy was performed, and macroscopic and microscopic inflammation scoring was determined. The Clostridium butyricum derivative effectively prevented bloody diarrhea. In addition, mucosal damage to the derivative-fed group was significantly reduced macroscopically compared to that of the control-fed group. The potential clinical efficacy of the Clostridium butyricum derivative in IBD patients is also discussed.
Similar articles
-
Short-term oral administration of a product derived from a probiotic, Clostridium butyricum induced no pathological effects in rats.Int J Mol Med. 2002 Feb;9(2):173-7. Int J Mol Med. 2002. PMID: 11786929
-
The long-term oral administration of a product derived from a probiotic, Clostridium butyricum induced no pathological effects in rats.Int J Mol Med. 2003 Oct;12(4):571-5. Int J Mol Med. 2003. PMID: 12964036
-
The dietary combination of germinated barley foodstuff plus Clostridium butyricum suppresses the dextran sulfate sodium-induced experimental colitis in rats.Scand J Gastroenterol. 2000 Oct;35(10):1060-7. doi: 10.1080/003655200451180. Scand J Gastroenterol. 2000. PMID: 11099059
-
Lessons from probiotic-host interaction studies in murine models of experimental colitis.Mol Nutr Food Res. 2011 Oct;55(10):1441-53. doi: 10.1002/mnfr.201100139. Epub 2011 Jul 28. Mol Nutr Food Res. 2011. PMID: 21796777 Review.
-
Probiotic-related Clostridium butyricum bacteremia: a case report and literature review.Anaerobe. 2023 Oct;83:102770. doi: 10.1016/j.anaerobe.2023.102770. Epub 2023 Aug 5. Anaerobe. 2023. PMID: 37544356 Review.
Cited by
-
Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?Gut. 2006 Dec;55(12):1692-3. doi: 10.1136/gut.2004.051458. Gut. 2006. PMID: 17124152 Free PMC article.
-
Bile salt hydrolase of Lactiplantibacillus plantarum plays important roles in amelioration of DSS-induced colitis.iScience. 2023 Feb 13;26(3):106196. doi: 10.1016/j.isci.2023.106196. eCollection 2023 Mar 17. iScience. 2023. PMID: 36895642 Free PMC article.
-
Study on the Potential Biomarkers of Maternal Urine Metabolomics for Fetus with Congenital Heart Diseases Based on Modified Gas Chromatograph-Mass Spectrometer.Biomed Res Int. 2019 May 6;2019:1905416. doi: 10.1155/2019/1905416. eCollection 2019. Biomed Res Int. 2019. PMID: 31198782 Free PMC article.
-
The gastrointestinal microbiota and colorectal cancer.Am J Physiol Gastrointest Liver Physiol. 2015 Mar 1;308(5):G351-63. doi: 10.1152/ajpgi.00360.2012. Epub 2014 Dec 24. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 25540232 Free PMC article. Review.
-
Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Br J Clin Pharmacol. 2008 Apr;65(4):453-67. doi: 10.1111/j.1365-2125.2008.03096.x. Epub 2008 Feb 12. Br J Clin Pharmacol. 2008. PMID: 18279467 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous